Skip to content

Clinical trials

Phase 3 Crohn Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Crohn Disease Phase: Phase 3 Country / region: Canada Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20047
20053
20069
20074
20083
20091
20103
20118
20131
20141
20154
20165
20178
20188
20191
20203
20211
20222
20233
20245
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed50
Terminated15
Recruiting13
Active, not recruiting8
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie11
Celgene7
Janssen Research & Development, LLC7
Takeda7
Eli Lilly and Company5
UCB Pharma5
Abbott4
GlaxoSmithKline4
Genzyme, a Sanofi Company2
Hoffmann-La Roche2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Crohn Disease89
Inflammatory Bowel Diseases14
Colitis, Ulcerative5
Colitis4
Inflammation3
Bone Diseases, Metabolic1
Colorectal Neoplasms1
Fistula1
Gastroenteritis1
Intestinal Fistula1

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.